The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study
Open accessAbstract
OBJECTIVES: To assess the performance of a panel of common single nucleotide polymorphisms (genotypes) associated with type 2 diabetes in distinguishing incident cases of future type 2 diabetes (discrimination), and to examine the effect of adding genetic information to previously validated non-genetic (phenotype based) models developed to estimate the absolute risk of type 2 diabetes. DESIGN: Workplace based prospective cohort study with three 5 yearly medical screenings. PARTICIPANTS: 5535 initially healthy people (mean age 49 years; 33% women), of whom 302 developed new onset type 2 diabetes over 10 years. OUTCOME MEASURES: Non-genetic variables included in two established risk models-the Cambridge type 2 diabetes risk score (age, sex, drug treatment, family history of type 2 diabetes, body mass index, smoking status) and the Framingham offspring study type 2 diabetes risk score (age, sex, parental history of type 2 diabetes, body mass index, high density lipoprotein cholesterol, triglycerides, fasting glucose)-and 20 single nucleotide polymorphisms associated with susceptibility to type 2 diabetes. Cases of incident type 2 diabetes were defined on the basis of a standard oral glucose tolerance test, self report of a doctor's diagnosis, or the use of anti-diabetic drugs. RESULTS: A genetic score based on the number of risk alleles carried (range 0-40; area under receiver operating characteristics curve 0.54, 95% confidence interval 0.50 to 0.58) and a genetic risk function in which carriage of risk alleles was weighted according to the summary odds ratios of their effect from meta-analyses of genetic studies (area under receiver operating characteristics curve 0.55, 0.51 to 0.59) did not effectively discriminate cases of diabetes. The Cambridge risk score (area under curve 0.72, 0.69 to 0.76) and the Framingham offspring risk score (area under curve 0.78, 0.75 to 0.82) led to better discrimination of cases than did genotype based tests. Adding genetic information to phenotype based risk models did not improve discrimination and provided only a small improvement in model calibration and a modest net reclassification improvement of about 5% when added to the Cambridge risk score but not when added to the Framingham offspring risk score. CONCLUSION: The phenotype based risk models provided greater discrimination for type 2 diabetes than did models based on 20 common independently inherited diabetes risk alleles. The addition of genotypes to phenotype based risk models produced only minimal improvement in accuracy of risk estimation assessed by recalibration and, at best, a minor net reclassification improvement. The major translational application of the currently known common, small effect genetic variants influencing susceptibility to type 2 diabetes is likely to come from the insight they provide on causes of disease and potential therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
Faith, M. S., Carnell, S., & Kral, T. V. E. (2013) · Human Heredity · doi:10.1159/000353879 · Cited by 7,601
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Lippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
Health inequalities among British civil servants: the Whitehall II study
Marmot, M. G., Stansfeld, S., Patel, C., North, F., Head, J., White, I., Brunner, E., Feeney, A., Marmot, M. G., & Smith, G. D. (1991) · The Lancet · doi:10.1016/0140-6736(91)93068-k · Cited by 3,608
Self-citationCardiovascular Survey Methods.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,052
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 1×
“As a technology, however, genotype based tests have several inherent advantages over non-genetic tests. Genotype based assays are cheap, have high fidelity, and can be multiplexed, in contrast to multiple phenotypic risk factors and biomarkers, many of which require different methods for their measurement, and which a…”
BackgroundGenome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Wellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864
Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459
Confidence interval estimation of interaction
Hosmer, D. W., & Lemeshow, S. (1992) · Epidemiology · doi:10.1097/00001648-199209000-00012 · Cited by 1,239
Gillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171
Clinical risk factors, DNA variants, and the development of type 2 diabetes
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., & Groop, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801869 · Cited by 938
Cohort Profile: The Whitehall II study
Marmot, M., & Brunner, E. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyh372 · Cited by 788
Self-citationGenotype score in addition to common risk factors for prediction of type 2 diabetes
Meigs, J. B., Shrader, P., Sullivan, L. M., McAteer, J. B., Fox, C. S., Dupuis, J., Manning, A. K., Florez, J. C., Wilson, P. W. F., D'Agostino, R. B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804742 · Cited by 759 · cited 1×
“rs3792267 was associated with significant differences in concentrations of total cholesterol and low density lipoprotein cholesterol (P=0.01). We found no other associations between genotypes and phenotypes included in either of the non-genetic risk models at phase 3 or phase 7 (web tables D-J). The point estimates of…”
ResultInfluentialKeating, B. J., Tischfield, S., Murray, S. S., Bhangale, T., Price, T. S., Glessner, J. T., Galver, L., Barrett, J. C., Grant, S. F. A., Farlow, D. N., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003583 · Cited by 376
Hippisley-Cox, J., Coupland, C., Robson, J., Sheikh, A., & Brindle, P. (2009) · BMJ · doi:10.1136/bmj.b880 · Cited by 372
Lango, H., the U.K. Type 2 Diabetes Genetics Consortium, Palmer, C. N. A., Morris, A. D., Zeggini, E., Hattersley, A. T., McCarthy, M. I., Frayling, T. M., & Weedon, M. N. (2008) · Diabetes · doi:10.2337/db08-0504 · Cited by 294
Predicting Type 2 Diabetes Based on Polymorphisms From Genome-Wide Association Studies
van Hoek, M., Dehghan, A., Witteman, J. C. M., van Duijn, C. M., Uitterlinden, A. G., Oostra, B. A., Hofman, A., Sijbrands, E. J. G., & Janssens, A. C. J. W. (2008) · Diabetes · doi:10.2337/db08-0425 · Cited by 280
Population-Based Incidence Rates and Risk Factors for Type 2 Diabetes in White Individuals
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Meigs, J. B., Bonadonna, R. C., & Muggeo, M. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1782 · Cited by 270
Combining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease Prediction
Weedon, M. N., McCarthy, M. I., Hitman, G., Walker, M., Groves, C. J., Zeggini, E., Rayner, N. W., Shields, B., Owen, K. R., Hattersley, A. T., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030374 · Cited by 268
Scott, L. J., Bonnycastle, L. L., Willer, C. J., Sprau, A. G., Jackson, A. U., Narisu, N., Duren, W. L., Chines, P. S., Stringham, H. M., Erdos, M. R., et al. (2006) · Diabetes · doi:10.2337/db06-0341 · Cited by 236
Thakkinstian, A., Han, P., McEvoy, M., Smith, W., Hoh, J., Magnusson, K., Zhang, K., & Attia, J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl220 · Cited by 223
New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function
Perry, J. R. B., & Frayling, T. M. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32830349a1 · Cited by 182
Impact of Common Type 2 Diabetes Risk Polymorphisms in the DESIR Prospective Study
Vaxillaire, M., Veslot, J., Dina, C., Cavalcanti-Proença, C., Cauchi, S., Charpentier, G., Tichet, J., Fumeron, F., Marre, M., Meyre, D., et al. (2007) · Diabetes · doi:10.2337/db07-0615 · Cited by 171
Cauchi, S., Meyre, D., Durand, E., Proença, C., Marre, M., Hadjadj, S., Choquet, H., De Graeve, F., Gaget, S., Allegaert, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002031 · Cited by 165
Song, Y., Niu, T., Manson, J. E., Kwiatkowski, D. J., & Liu, S. (2004) · The American Journal of Human Genetics · doi:10.1086/381400 · Cited by 151
Talmud, P. J., Cooper, J. A., Palmen, J., Lovering, R. C., Drenos, F., Hingorani, A. D., & Humphries, S. E. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.095489 · Cited by 147
Self-citationRahman, M., Simmons, R. K., Harding, A.-H., Wareham, N. J., & Griffin, S. J. (2008) · Family Practice · doi:10.1093/fampra/cmn024 · Cited by 126
Lin, X., Song, K. S., Lim, N., Yuan, X., Johnson, T., Abderrahmani, A., Vollenweider, P., Stirnadel-Farrant, H. A., Sundseth, S. S., Lai, E., et al. (2009) · Diabetologia · doi:10.1007/s00125-008-1254-y · Cited by 119
Cook, N. R. (2007) · Statistics in Medicine · doi:10.1002/sim.2987 · Cited by 102
Hanning, I., Home, P. D., & Alberti, K. G. M. M. (1985) · Diabetologia · doi:10.1007/bf00291073 · Cited by 76
Methods for Determining the Amount of Glucose in Blood
Cooper, G. R. (1973) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408367309151554 · Cited by 73
Sparsø, T., Grarup, N., Andreasen, C. H., Albrechtsen, A., Holmkvist, J., Andersen, G., Jørgensen, T., Borch‐Johnsen, K., Sandbæk, A., Lauritzen, T., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1362-3 · Cited by 58
Weedon, M. N., Owen, K. R., Shields, B. M., Hitman, G. A., Walker, M., McCarthy, M. I., Hattersley, A. T., & Frayling, T. M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2487 · Cited by 55
Genome-wide association study for type 2 diabetes: clinical applications
Lyssenko, V., & Groop, L. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832923af · Cited by 44
Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study
Wilson, P. W. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1068 · Cited by 4
Cited by
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
Houle, D., Govindaraju, D. R., & Omholt, S. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2897 · Cited by 1,279
Epidemiological studies of CHD and the evolution of preventive cardiology
Wong, N. D. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.26 · Cited by 658
Risk models and scores for type 2 diabetes: systematic review
Noble, D., Mathur, R., Dent, T., Meads, C., & Greenhalgh, T. (2011) · BMJ · doi:10.1136/bmj.d7163 · Cited by 551
O’Sullivan, J. W., Raghavan, S., Marquez-Luna, C., Luzum, J. A., Damrauer, S. M., Ashley, E. A., O’Donnell, C. J., Willer, C. J., Natarajan, P., & on behalf of the American Heart Association Council on Genomic and Precision Medicine; Council on Clinical Cardiology; Council on Arteriosclerosis, T. A. V. B. C. O. C. R. A. I. C. O. L. A. C. H. A. C. O. P. V. D. (2022) · Circulation · doi:10.1161/cir.0000000000001077 · Cited by 412
Metadata
- Authors
- Talmud, P. J., Hingorani, A. D., Cooper, J. A., Marmot, M. G., Brunner, E. J., Kumari, M., Kivimaki, M., & Humphries, S. E.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2010-01-14
- Volume
- 340
- Issue
- jan14 1
- Pages
- b4838-b4838
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2095403671
- Cited by
- 296
- References
- 51
- FWCI
- 24.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.